Holdings

Sarissa Capital Management LP

As of Sep 30, 2026, Sarissa Capital Management LP reported 10 positions worth US$153M. Largest: Innoviva, Inc., Ironwood Pharmaceuticals, Inc. and Amarin Corporation plc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Innoviva, Inc.1.89MUS$40.1Mno changeSep 30, 2026
Ironwood Pharmaceuticals, Inc.9.19MUS$36.5Mno changeSep 30, 2026
Amarin Corporation plc1.29MUS$16.7MnewSep 30, 2026
Lantheus Holdings, Inc.167KUS$16.6Mno changeSep 30, 2026
Neurocrine Biosciences, Inc.117KUS$16.5Mno changeSep 30, 2026
Cytokinetics, Incorporated229KUS$15.1Mno changeSep 30, 2026
Biohaven Ltd.582KUS$7.77Mno changeSep 30, 2026
Regeneron Pharmaceuticals, Inc.4,190US$3.18Mno changeSep 30, 2026
Vor Biopharma Inc.25,399US$485Kno changeSep 30, 2026
Biogen Inc.950US$215Kno changeSep 30, 2026